UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Journal of immunotherapy, 2009-06, Vol.32 (5), p.498-507

2009

Volltextzugriff (PDF)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants

Signal transduction and targeted therapy, 2021-07, Vol.6 (1), p.259-259, Article 259

2021

Volltextzugriff (PDF)

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty

Breast cancer research : BCR, 2017-02, Vol.19 (1), p.20-20, Article 20

2017

Volltextzugriff (PDF)

Unexpected benefits of aging for favorable responses to PD-1 blockade in melanoma?

Clinical cancer research, 2018-11, Vol.24 (21), p.5193-5194

Pawelec, Graham

2018

Volltextzugriff (PDF)

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

Journal of clinical oncology, 2012-05, Vol.30 (15), p.1835-1841

2012

Volltextzugriff (PDF)

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006802

2023

Volltextzugriff (PDF)

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

Cancer Immunology, Immunotherapy, 2009-09, Vol.58 (9), p.1517-1526

2009

Volltextzugriff (PDF)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Journal for immunotherapy of cancer, 2017-04, Vol.5 (1), p.39-39, Article 39

2017

Volltextzugriff (PDF)

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

Journal for immunotherapy of cancer, 2021-12, Vol.9 (12), p.e003439

2021

Volltextzugriff (PDF)

Relationships between cancer and aging: a multilevel approach

Biogerontology (Dordrecht), 2009-08, Vol.10 (4), p.323-338

2009

Volltextzugriff (PDF)

Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma

Cancer Immunology, Immunotherapy, 2010-08, Vol.59 (8), p.1273-1284

2010

Volltextzugriff (PDF)

The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6–8 October 2015, Tübingen, Germany: looking back on 15 years of progress

Cancer Immunology, Immunotherapy, 2017-02, Vol.66 (2), p.273-279

2017

Volltextzugriff (PDF)

Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015

Cancer Immunology, Immunotherapy, 2015-09, Vol.64 (9), p.1071-1074

2015

Volltextzugriff (PDF)

Immunosenescence and cancer

Critical reviews in oncology/hematology, 2010-08, Vol.75 (2), p.165-172

2010

Volltextzugriff (PDF)

Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

Cancer Immunology, Immunotherapy, 2007-03, Vol.56 (3), p.371-379

2007

Volltextzugriff (PDF)

Professor Enrico Mihich, 1928–2016

Cancer Immunology, Immunotherapy, 2017-07, Vol.66 (7), p.955-957

2017

Volltextzugriff (PDF)

In memory of Professor Enrico Mihich: Editor-in-Chief of Cancer Immunology, Immunotherapy 1982–2012

Cancer Immunology, Immunotherapy, 2017-04, Vol.66 (4), p.549-549

2017

Volltextzugriff (PDF)

Tumour escape: antitumour effectors too much of a good thing?

Cancer Immunology, Immunotherapy, 2004-03, Vol.53 (3), p.262-274

PAWELEC, Graham

2004

Volltextzugriff (PDF)

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-06, Vol.22 (12), p.2908-2918

2016

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

Clinical cancer research, 2014-03, Vol.20 (6), p.1601-1609

2014

Volltextzugriff (PDF)

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy

Cancer Immunology, Immunotherapy, 2018-12, Vol.67 (12), p.1845-1851

2018

Volltextzugriff (PDF)

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

Seminars in cancer biology, 2015-12, Vol.35, p.S185-S198

2015

Volltextzugriff (PDF)

The nascent field of AllergoOncology

Cancer Immunology, Immunotherapy, 2012-09, Vol.61 (9), p.1355-1357

2012

Volltextzugriff (PDF)

Natural killer cells, ageing and cancer

Cancer Immunology, Immunotherapy, 2016-04, Vol.65 (4), p.367-370

2016

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(90)
Buchkapitel
(2)

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty

Unexpected benefits of aging for favorable responses to PD-1 blockade in melanoma?

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

Relationships between cancer and aging: a multilevel approach

Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma

The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6–8 October 2015, Tübingen, Germany: looking back on 15 years of progress

Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015

Immunosenescence and cancer

Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

Professor Enrico Mihich, 1928–2016

In memory of Professor Enrico Mihich: Editor-in-Chief of Cancer Immunology, Immunotherapy 1982–2012

Tumour escape: antitumour effectors too much of a good thing?

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

The nascent field of AllergoOncology

Natural killer cells, ageing and cancer

Aktive Filter

Suchergebnisse filtern